Search research articles
Contact Us
Filters
Showing results (41-50 of 132) with videos related to
Page
of 14
Sort By:
Molecular and Cellular Biology
|
December 1, 1991
A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers
T Morinaga, H Yasuda, T Hashimoto, et al.
Cancer Biochemistry Biophysics
|
October 1, 1986
Mythylation of human HLA-D/DR genes: derangement in chronic lymphocytic leukemia
H Tobe, B A Ruether, L M Jerry, et al.
The Journal of Biological Chemistry
|
January 15, 1992
A possible mechanism of inverse developmental regulation of alpha-fetoprotein and albumin genes. Studies with epidermal growth factor and phorbol ester
K Nakata, M Motomura, H Nakabayashi, et al.
Japanese Journal of Cancer Research : Gann
|
February 9, 2000
G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation
T Akiyama, K Sugiyama, M Shimizu, et al.
Anti-Cancer Drugs
|
April 9, 1999
Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole
T Akiyama, M Shimizu, M Okabe, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration
T Takahashi, J Kanazawa, S Akinaga, et al.
Life Sciences
|
January 1, 1996
A new alternative splice variant of the mouse Fas antigen with a deletion in the N-terminal portion of the extracellular domain
T Nakajima, S Ichii, J Furuyama, et al.
Anti-Cancer Drugs
|
October 17, 1998
The relationship between the antitumor activity and the ribonucleotide reductase inhibitory activity of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, MDL 101,731
J Kanazawa, T Takahashi, S Akinaga, et al.
The Journal of Antibiotics
|
August 1, 1982
Tetrocarcins, new antitumor antibiotics. 3. Antitumor activity of tetrocarcin A
M Morimoto, M Fukui, S Ohkubo, et al.
Acta Haematologica
|
January 1, 1997
Characterization of the molecules involved in the hematopoietic microenvironment provided by mouse stromal cell line MC3T3-G2/PA6 using a unique reporter system that analyzes the direct cell-to-cell interaction
M Satoh, H Mioh, N Konishi, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 132) with videos related to
Sort By:
Page
of 14
Molecular and Cellular Biology
|
December 1, 1991
A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers
T Morinaga, H Yasuda, T Hashimoto, et al.
Cancer Biochemistry Biophysics
|
October 1, 1986
Mythylation of human HLA-D/DR genes: derangement in chronic lymphocytic leukemia
H Tobe, B A Ruether, L M Jerry, et al.
The Journal of Biological Chemistry
|
January 15, 1992
A possible mechanism of inverse developmental regulation of alpha-fetoprotein and albumin genes. Studies with epidermal growth factor and phorbol ester
K Nakata, M Motomura, H Nakabayashi, et al.
Japanese Journal of Cancer Research : Gann
|
February 9, 2000
G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation
T Akiyama, K Sugiyama, M Shimizu, et al.
Anti-Cancer Drugs
|
April 9, 1999
Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole
T Akiyama, M Shimizu, M Okabe, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration
T Takahashi, J Kanazawa, S Akinaga, et al.
Life Sciences
|
January 1, 1996
A new alternative splice variant of the mouse Fas antigen with a deletion in the N-terminal portion of the extracellular domain
T Nakajima, S Ichii, J Furuyama, et al.
Anti-Cancer Drugs
|
October 17, 1998
The relationship between the antitumor activity and the ribonucleotide reductase inhibitory activity of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, MDL 101,731
J Kanazawa, T Takahashi, S Akinaga, et al.
The Journal of Antibiotics
|
August 1, 1982
Tetrocarcins, new antitumor antibiotics. 3. Antitumor activity of tetrocarcin A
M Morimoto, M Fukui, S Ohkubo, et al.
Acta Haematologica
|
January 1, 1997
Characterization of the molecules involved in the hematopoietic microenvironment provided by mouse stromal cell line MC3T3-G2/PA6 using a unique reporter system that analyzes the direct cell-to-cell interaction
M Satoh, H Mioh, N Konishi, et al.
Page
of 14